GSK & VIR drug reduces hospital admission & death by 85% - effective against Covid 19 & variants including for people with mild to moderate illnesses. They already applied for emergency use.
This treatment shows ‘profound efficacy’ in initial trial.
GSK on a 3.59% 5day increase and VIR at 51.76%. Expecting a good trading days ahead.
https://zyne.com/stock/GSK
This treatment shows ‘profound efficacy’ in initial trial.
GSK on a 3.59% 5day increase and VIR at 51.76%. Expecting a good trading days ahead.
https://zyne.com/stock/GSK
